Eka.Care Raises $15 Million in Series A Funding

Amit Bharti
on
June 8, 2022

Eka.Care, the innovative healthcare technology startup, has successfully raised $15 million in its Series A funding round. This significant investment marks a major milestone for the company and the Indian healthtech sector.

Founded in 2020, Eka.Care aims to revolutionize healthcare delivery in India through its digital platform. The company's core offerings include:

• Telemedicine services
• Electronic health records
• Appointment scheduling
• Medicine delivery

The fresh capital will be utilized to:

  1. Expand the company's user base
  2. Enhance the platform's features
  3. Strengthen partnerships with healthcare providers

"This funding will accelerate our mission to make quality healthcare accessible to every Indian," said the CEO of Eka.Care.

Industry experts believe this investment signals growing confidence in India's digital health ecosystem. For more information about Eka.Care and its services, visit their official website.

Are you excited about the future of digital healthcare in India? Share your thoughts in the comments below!

‍

Related posts

New Guidelines Recommend Metformin for Managing Antipsychotic Weight Gain

A recently published guideline in the Schizophrenia Bulletin offers clear recommendations on using metformin to prevent weight gain associated with antipsychotic medications. Developed by researchers led by Aoife Carolan, Saint John of God Hospital and the Royal College of Surgeons, Ireland, the guidance aims to address a critical side effect of antipsychotic treatment.
December 21, 2024

AIIMS Develops Affordable CAR T-Cell Therapy for Blood Cancer in India

In a groundbreaking development, researchers at AIIMS Delhi have made significant strides in creating an affordable Chimeric Antigen Receptor (CAR) T-cell therapy to treat multiple myeloma, a type of blood cancer. The therapy, which genetically modifies a patient’s T cells to enhance cancer-fighting abilities, has shown promising results in initial animal trials.
December 20, 2024

Russia Unveils Revolutionary Cancer mRNA Vaccine for 2025 Rollout

In a groundbreaking advancement for oncology, Russia has announced the development of a personalized mRNA cancer vaccine, set to be launched in early 2025 and provided free of charge to its citizens. The announcement, made by Andrey Kaprin, head of the Radiology Medical Research Centre, highlights the vaccine’s potential to transform cancer treatment by training the immune system to identify and destroy cancer cells.
December 19, 2024

Delhi Air Turns ‘Severe’: Schools Go Hybrid, Work-From-Home Urged

Delhi’s air quality has plummeted to the ‘severe’ category once again, triggering Stage-IV restrictions under the Graded Response Action Plan (GRAP). The Commission for Air Quality Management (CAQM) announced emergency curbs to combat the alarming pollution spike, driven by stagnant weather, low wind speed, and dense fog.
December 17, 2024

India’s First Diabetes Biobank Unveiled in Chennai for Advanced Research

India’s first diabetes biobank, a pioneering initiative by the Indian Council of Medical Research (ICMR) in collaboration with the Madras Diabetes Research Foundation (MDRF), has been launched in Chennai. This state-of-the-art repository aims to revolutionize diabetes research by storing, processing, and distributing biological samples to support advanced studies on diabetes and its complications.
December 16, 2024

Revolutionary Gene Therapy for Hemophilia A Developed in India

In a landmark achievement, Indian scientists have successfully trialed a novel gene therapy for severe Hemophilia A, potentially eliminating the need for frequent and costly clotting factor injections. The trial, conducted by Dr. Alok Srivastava and his team at the Centre for Stem Cell Research (CSCR), Christian Medical College, Vellore, involved five patients who reported no bleeding episodes over 14 months. The study was recently published in the prestigious New England Journal of Medicine (NEJM).
December 13, 2024

Cipla Brings Inhaled Insulin to India

Cipla Limited, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) to distribute and market Afrezza®, a groundbreaking inhaled insulin, in India. This innovation, developed by MannKind Corporation (USA), marks a significant step in diabetes care, providing a needle-free alternative for managing both type 1 and type 2 diabetes mellitus.
December 12, 2024

Urine Test Breakthrough for Early Lung Cancer Detection

Cambridge scientists have developed a groundbreaking urine test that could revolutionize early lung cancer detection. The test targets “zombie” cells - damaged cells that linger in tissue and release proteins that aid cancer development. This innovation could enable earlier interventions, improving survival rates for the world’s deadliest cancer.
December 10, 2024

“Disease X” Outbreak in Congo Sparks Global Health Alert, Claims 79 Lives.

A mysterious and flu-like illness, dubbed Disease X, has claimed 79 lives and affected 376 individuals in the Democratic Republic of Congo since its emergence in late October. Nearly 200 of the cases involve children under five, while most fatalities are reported among adolescents aged 15 to 18.
December 9, 2024

Maternal Deaths Spark Investigation in Karnataka Hospital

A series of maternal deaths following caesarean deliveries at the government-run Ballari District Hospital, Karnataka, has sent shockwaves through the medical community, prompting an intense investigation into the safety of medical supplies. Between November 9 and 11, four women succumbed to complications, and three others required critical care, including haemodialysis for acute kidney injury and treatment for multi-organ dysfunction.
December 7, 2024

Delhi Breathes Easier : SC Eases GRAP-4 Restrictions as AQI Improves

In a significant relief for Delhi-NCR, the Supreme Court on Thursday allowed relaxation of GRAP-4 restrictions, as the Air Quality Index (AQI) improved to a ‘moderate’ 161 after weeks of hazardous levels. The Commission for Air Quality Management (CAQM) has now reverted to GRAP-2 measures, retaining stricter curbs from GRAP-3 to prevent a relapse into toxic air conditions.
December 6, 2024

WHO Prequalified Tool to Fight TB: A Faster, More Accurate Test

The World Health Organization (WHO) has prequalified the Xpert® MTB/RIF Ultra, the first molecular diagnostic test for tuberculosis (TB) and antibiotic susceptibility testing to meet WHO’s stringent quality, safety, and performance standards. This innovative test detects mycobacterium tuberculosis and rifampicin resistance within hours, providing a crucial tool to combat drug-resistant TB and improve early diagnosis and treatment.
December 5, 2024

Revolutionizing Cancer Detection: Introducing the CancerSpot Blood Test

Strand Life Sciences, a Reliance Industries subsidiary, launches CancerSpot, a groundbreaking blood-based test for early detection of multiple cancers. Using cutting-edge methylation profiling technology, the test identifies tumor DNA fragments from a simple blood sample, enabling proactive cancer screening like never before.
December 4, 2024

"Bleeding Eye" Virus: Marburg Outbreak Claims Lives in Rwanda, Triggers Global Alert

The deadly Marburg virus, also known as the “Bleeding Eye” virus due to its severe symptoms, has claimed at least 15 lives in Rwanda and infected hundreds across 17 countries, including parts of Africa and South America, over the past two months. The outbreak has prompted international health advisories urging travelers to exercise caution.

New Breakthrough in Asthma and COPD Care: A “Game-Changer” Treatment Emerges

A groundbreaking study published in The Lancet Respiratory Medicine has revealed a potential revolution in managing asthma and COPD flare-ups. Researchers at King’s College London have found that benralizumab, a monoclonal antibody already used in severe eosinophilic asthma cases, could now offer critical relief during acute flare-ups.

India Surpasses WHO Benchmark in Doctor-Population Ratio: A Healthcare Milestone

India’s healthcare system has achieved a significant milestone with a doctor-population ratio of 1:811, surpassing the WHO standard of 1:1000, according to Union Health Minister J.P.Nadda. The minister, addressing the Lok Sabha, credited this improvement to the increase in medical education infrastructure. “The number of medical colleges has surged by 102% from 387 in 2014 to 780 now, with MBBS seats increasing by 130% to 1,18,137,” he noted.

Isolated Case of Japanese Encephalitis Reported in Delhi

An isolated case of Japanese Encephalitis (JE) has been reported in Delhi, sparking health concerns amid the city’s ongoing battle against air pollution. A 72-year-old diabetic man from Uttam Nagar, West Delhi, tested positive for JE during his treatment at AIIMS. The diagnosis was confirmed via IgM ELISA on November 6, following his admission for chest pain on November 3. After receiving supportive care, he was discharged on November 15.

New Rule Expands Kidney and Liver Transplant Options for HIV-Positive Patients in the US

In a groundbreaking move, the United States has officially removed restrictions on kidney and liver transplants from HIV-positive donors to HIV-positive recipients. Previously limited to research studies, this new rule aims to expand the organ donor pool and shorten wait times for all transplant patients, regardless of HIV status.

Govt’s New TB Supplement Sparks Expert Concerns Amid Pending Trial Results

The government has recently approved the rollout of Energy Dense Nutritional Supplementation (EDNS) for 12 lakh underweight tuberculosis (TB) patients, despite pending trial results on its efficacy. The sachets, containing sweetened peanut paste, milk powder, and oil, will replace traditional food support for two months. However, experts warn this decision may commercialize care and prove costlier than providing a food basket, a proven intervention recommended by a landmark trial.

Neuralink Advances Brain Implant Feasibility Trials for Quadriplegia

Neuralink, Elon Musk’s brain-tech startup, has announced the launch of a groundbreaking feasibility study for its wireless brain-computer interface and experimental robotic arm. The study, approved by Health Canada and now expanding in the U.S., aims to empower patients with quadriplegia to control external devices using their thoughts.

Experts Dismiss Navjot Sidhu’s Claims on Wife’s Cancer Recovery

Tata Memorial Hospital oncologists have strongly refuted claims made by Congress leader Navjot Singh Sidhu about his wife Navjot Kaur Sidhu’s recovery from stage 4 cancer through a dietary regimen. Sidhu, in a widely circulated video, attributed her recovery to practices such as intermittent fasting, avoiding sugar and dairy, consuming turmeric, neem water and apple cider vinegar. He claimed these methods played a critical role in her survival.

Delhi Smog Crisis: AQI Hits ‘Severe’ with 421, Raising Health Concerns

Delhi’s air quality has plunged into the “severe” category, recording an overall Air Quality Index (AQI) of 421 this morning. With several areas exceeding AQI 450, doctors and healthcare experts are raising alarms over the potential spike in respiratory and cardiovascular issues among residents.

India’s First Indigenous Antibiotic Nafithromycin: A Game-Changer in Drug-Resistant Pneumonia

In a landmark development for India’s healthcare and biotechnology sectors, Union Minister Dr. Jitendra Singh announced the soft launch of Nafithromycin, India’s first indigenously developed antibiotic designed to combat Antimicrobial Resistance (AMR). Developed by Wockhardt with support from the Biotechnology Industry Research Assistance Council (BIRAC), Nafithromycin offers unparalleled efficacy in treating Community-Acquired Bacterial Pneumonia (CABP) caused by drug-resistant pathogens.

New Clinical Trial Revolutionizes Hypertension Treatment in India

AIIMS Bhubaneswar Achieves Medical Milestone with First Successful eCPR in Odisha

Doctors at AIIMS Bhubaneswar successfully revived a 24-year-old Army soldier whose heart had stopped for nearly 90 minutes. The young soldier, hailing from Nayagarh district, was brought back to life using the advanced Extracorporeal Cardiopulmonary Resuscitation (eCPR) procedure, marking the first successful case of its kind in the state.

World AMR Awareness Week: Combating Antimicrobial Resistance with Equity and Precision

The global spotlight is on antimicrobial resistance (AMR) during World AMR Awareness Week (November 18 to 24), with experts warning about the grave threats posed by the misuse and overuse of medicines. AMR undermines the efficacy of antibiotics and other antimicrobials, making once-treatable infections harder to manage and increasing the risk of severe illness, disability, and death.

No Need for a 'Separate Central Law' for Violence Against Healthcare workers, Says National Task Force to Supreme Court

In a significant development for the safety of healthcare professionals, the National Task Force (NTF), constituted by the Supreme Court, has concluded that existing State laws and the Bharatiya Nyaya Sanhita (BNS)2023 are sufficient to address violence against medical professionals. The taskforce dismissed the demand for a separate central law, citing that 24 states already have specific laws in place, with two more states drafting similar legislation.

Tragic Fire at Jhansi Hospital Claims 10 Newborns, Leaves 16 Battling for Life

A devastating fire broke out late Friday night in the neonatal intensive care unit (NICU) of Maharani Laxmi Bai Medical College, Jhansi, Uttar Pradesh, claiming the lives of 10 newborns and leaving 16 others critically injured. The blaze, reportedly caused by a short circuit, created a stampede-like situation as frantic parents and hospital staff scrambled to rescue infants.

India’s Diabetes Crisis: Early Detection and Lifestyle Changes Key to Prevention

Diabetes in India is spreading beyond urban areas, now affecting suburban and rural populations, with a rise in cases among younger individuals and more women. Non-compliance in treatment remains a major challenge, as patients often follow non-expert advice, impacting their health outcomes despite knowing the risks. Advances in diabetes management over the past two decades have significantly broadened treatment options, including various oral medications and non-insulin injections that not only control blood sugar but also protect vital organs, improving patients’ quality of life.

Tragic Attack on Doctor at Chennai’s KCSSH Sparks National Outcry

In a shocking incident at the Kalaignar Centenary Super Speciality Hospital (KCSSH) in Chennai, Dr. Balaji Jagannath, an associate professor of Medical Oncology, was attacked on duty by the family member of a patient on Wednesday morning, November 13, 2024.

AI-Powered Eye Surgery Restores Vision Beyond 20/20 for Legally Blind Patient

In a pioneering achievement at Focus Clinics in London, UK, a 31-year-old legally blind woman from Portugal, Patrícia Gonçalves, has regained her sight through an AI-powered LASIK procedure. This groundbreaking surgery, supervised by Dr. David Allamby, marks a major milestone in medical technology, utilizing AI to push the boundaries of vision restoration.

Alarming Rise in Pollution-Related Health Issues: 4 in 10 Delhi-NCR Families Seek Medical Attention Amid ‘Very Poor’ Air Quality

A recent survey conducted by community platform LocalCircles reveals a concerning trend in Delhi-NCR, with 40% of families reporting that at least one member has sought medical care for pollution-related ailments within the last three weeks. This spike in health issues comes as air quality in the capital region remains in the ‘very poor’ category, according to the Central Pollution Control Board (CPCB). Delhi recorded an Air Quality Index (AQI) of 349 on Monday morning, with even more severe readings in Bawana and Jahangirpuri, where AQI levels exceeded 400.

New Global Guidelines for Type 2 Diabetes Prioritize Patient-Centered Care

The International Diabetes Federation (IDF) is finalizing updated global guidelines for Type 2 diabetes management, set to be launched during the World Congress in Bangkok, April 2025. These guidelines were developed with a flexible approach to assist countries in providing patient-centred diabetes care that adapts to their specific settings and capabilities.

Gut Microbe Changes Signal Early Rheumatoid Arthritis Risk

A new study published in the Annals of the Rheumatic Diseases has reported on a connection between changes in gut microbiota to the early onset of rheumatoid arthritis (RA), suggesting that specific bacterial strains in the gut could serve as early indicators for RA in high-risk individuals. The study observed 124 individuals over 15 months, with 30 eventually developing rheumatoid arthritis. Researchers found that changes in certain bacterial strains, particularly from the Prevotellaceae family, became apparent around 10 months before the onset of clinical RA.

Indian Experts Call for Obesity to Be Recognized as a Chronic Disease for Better Management

In a recent study by Novo Nordisk, involving 2,000 individuals with obesity (PwO) and 300 healthcare professionals in India, findings revealed the significant need for a comprehensive, sustained strategy to manage obesity. Dr. Maya Sharma, Vice President of Clinical, Medical, and Regulatory at Novo Nordisk India, highlighted the importance of going beyond basic lifestyle modification to support PwO. “Effective obesity management demands tools that not only promote initial weight loss but also help maintain it,” she stated.

IL-35: A Breakthrough in Immunotherapy for Type 1 and Autoimmune Diabetes

A recent study discovered that Interleukin-35 (IL-35), an immune-regulatory protein, offers significant potential for treating type 1 diabetes and autoimmune diabetes mellitus. By reducing the activity of certain immune cells that produce inflammatory chemicals, IL-35 minimizes pancreatic cell infiltration, a primary factor in these diseases.

Tirzepatide: A Breakthrough in Diabetes Prevention

At the recent ObesityWeek conference, new data from the SURMOUNT-1 trial demonstrated that once-weekly tirzepatide (Zepbound) prevents the progression from pre diabetes to type 2 diabetes (T2D) by over 90% at three years, with significant and sustained weight loss benefits. Presented by Eli Lilly, these findings have ignited hope for a new era in long-term diabetes prevention.

FSSAI's New Regulations to Combat Antimicrobial Resistance (AMR)

New norms for antibiotic residues in food products have been issued by the Food Safety and Standards Authority of India (FSSAI) in an effort to address the critical issue of antimicrobial resistance (AMR). Starting from April 1, 2025, the new regulations will impose stricter limits on antibiotics in meat, milk, poultry, eggs, aquaculture and add more drugs to its watch list. FSSAI has also banned the use of antibiotics in honey production and revised the maximum permissible limits of ochratoxin A and deoxynivalenol in wheat, barley, rye, and coffee.

Reducing Early-Life Sugar Intake Lowers Chronic Disease Risk, Study Finds

Analyzing data from the U.K. Biobank researchers found that children exposed to sugar limitations in utero and during their first 1,000 days of life had up to a 35% lower risk of developing Type 2 diabetes and 20% lower chance of hypertension in adulthood. Moreover, if diagnosed, the onset of these conditions were delayed by four years for diabetes and two years for hypertension.

Supreme Court to Doctors: Not Every Bad Outcome is Negligence

The Supreme Court emphasized that complications or unsuccessful outcomes do not automatically indicate negligence. In order to prove negligence, clear evidence must demonstrate that the doctor deviated from accepted medical practices.

India Goes Digital for Vaccines with U-WIN Portal

Prime Minister Narendra Modi has launched U-WIN, an advanced online platform that aims to modernize India's immunization tracking for pregnant women and children. This initiative under the National Health Mission (NHM), enhances vaccine accessibility and strengthens data accuracy across the healthcare system.

Union Health Minister J.P. Nadda Launches Five Important DHR-ICMR Initiatives to Strengthen India's Health Research

‍In a significant move to advance India’s health research landscape, Union Health Minister JP Nadda has announced 5 major health research initiatives under the Department of Health Research-Indian Council of Medical Research (DHR-ICMR). These projects, under the government's 100-day agenda, aim to make India a leading global hub for health research and innovation, as envisioned in Viksit Bharat.

India to Launch Breakthrough 6-Month Regimen for Drug-Resistant TB in January: BPaL Treatment Promises New Hope

The National Tuberculosis Elimination Programme (NTEP) is set to roll out BPaL, the shortest treatment regimen for drug-resistant Tuberculosis (TB), nationwide in early January. This novel combination of Bedaquiline, Pretomanid and Linezolid has been associated with an impressive 90% cure rate and also a substantial reduction in the treatment duration.

Semaglutide Associated with Reduced Risk for Alzheimer Disease in Patients with Type 2 Diabetes

A new study published in Alzheimer's & Dementia suggests that, the active ingredient of Ozempic and Wegovy, semalutide could significantly decrease the risk of developing Alzheimer's disease among Type 2 diabetes patients. Patients taking semaglutide had up to a 70% lower risk of developing Alzheimer’s compared to those on other diabetes medications, including insulin and older GLP-1 drugs like Liraglutide.

Study Reveals Over 77% of Indian Children Miss Out on WHO-Recommended Diet Diversity

Over 80 per cent of children between the age group of 6 to 23 months have inadequate dietary diversity in Maharashtra, where one out four children are malnourished, as revealed by a study published in 'The National Medical Journal Of India'. The study highlights that these children fail to meet the World Health Organization’s (WHO) standards for Minimum Dietary Diversity.

WHO and Saudi Arabia Expand Digital Health Certification for Hajj Pilgrims

World Health Organization (WHO) expands digital health certification for Hajj pilgrims. It allows pilgrims to share their health data with authorized healthcare providers, ensuring personalized, high-quality care throughout their pilgrimage.

IMA President Calls for Legalization of Prenatal Gender Detection Tests

Three decades after India banned prenatal sex determination, Dr. RV Asokan, President of the Indian Medical Association (IMA), has called for its legalization, arguing that the ban has not significantly improved the country’s gender ratio.

Semaglutide: A Promising Drug for Weight Loss and Cardiovascular Health with Gastrointestinal Considerations

A recent meta-analysis in the International Journal of Obesity reveals that semaglutide, a GLP-1 receptor agonist, offers significant cardiovascular benefits and aids weight loss in overweight and obese patients, though its side effects warrant caution.

Study Reveals Declining Dental Benefits of Fluoridated Water

The dental health benefits of adding fluoride to drinking water have diminished since the introduction of fluoride toothpaste. Despite the decline, researchers emphasize that water fluoridation still provides benefits and should not be discontinued. The research emphasises the importance of a multi-faceted approach to oral health, consisting of reduced sugar consumption and good dental hygiene practices.

New Cheek Swab Test Predicts Mortality Risk and Biological Age

Scientists have developed a revolutionary tool called CheekAge that can predict biological aging and mortality risk using a simple cheek swab. While previous methods required blood samples, the new noninvasive tool tacks DNA changes in cheek cells caused by lifestyle habits such as stress, poor sleep quality, smoking, alcohol use and an unhealthy diet. Such factors quicken aging through imprinting epigenetic marks in DNA, which CheekAge analyses to predict biological age of individuals.

Arm Position: A Critical Factor in Blood Pressure Accuracy

According to a new study published in JAMA Internal Medicine, an incorrect posture during blood pressure measurements can result in readings that are higher than the actual blood pressure, potentially resulting in a misdiagnosis of high blood pressure and unnecessary treatment.

India Eliminates Trachoma: A Public Health Triumph

In a landmark achievement, India has been declared free of trachoma as a public health problem. This infectious eye disease, a leading cause of blindness, has been successfully eliminated through concerted efforts by the Indian government, healthcare workers and international organizations.

MicroRNA Researchers Win 2024 Nobel Prize in Medicine

The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA and its essential role in post-transcriptional gene regulation.
Eka Care
October 7, 2024

WHO Approves Single-Dose HPV Vaccine, Cecolin®

The World Health Organization (WHO) has approved the use of Cecolin®, a single-dose, as the fourth prequalified human papillomavirus (HPV) vaccine.The single-dose schedule has proven highly effective, with coverage among girls aged 9-14 increasing from 20% in 2022 to 27% in 2023. WHO estimates that this approach led to at least 6 million more girls receiving the HPV vaccine in 2023.
Eka Care
October 7, 2024

Breast Cancer Increasing Among Younger Women, Particularly Asian Americans

The American Cancer Society (ACS) published a report revealing mixed news regarding breast cancer trends in the U.S., while breast cancer deaths have decreased by 44% since the late 1980s, new diagnoses continue to rise year after year. This rise is greater among younger women, with rates increasing by 1.4% each year since 2021.
Eka Care
October 7, 2024

India Launches First Comprehensive Cancer Genomics Database

The Indian Cancer Genome Atlas (ICGA) has launched India's first cancer multi-omics data portal, a critical milestone in the goal to transform cancer care in the nation through personalised medicine. Jointly supported by public and private funders in India, the ICGA aims to update the previous dependence on western datasets for cancer research in India.
Eka Care
October 7, 2024

MediBuddy Partners with Philips for Advanced Heart Health Monitoring in India

This initiative aims to improve preventive heart care by allowing people to identify early indications and symptoms of a cardiac issue at home with the help of their smartphones.
Eka Care
October 4, 2024

NABH’s Digital Health Accreditation Gains Momentum

300 hospitals have applied so far, the accreditation process involves a self-evaluation and an external assessment across seven domains such as digital infrastructure, data security, information flow, and digital healthcare processes for patient management
Eka Care
October 4, 2024

WHO Partners with TikTok to Promote Reliable Health Information

The World Health Organization (WHO) and TikTok have announced a 1 year partnership to provide real science-based health knowledge by means of videos. This partnership will help tackle misinformation, and improve health literacy and encourage healthy behaviours on a global scale using TikTok wide reach.
Eka Care

CDSCO Warns of Quality Issues in Over 50 Drug Samples in Indian Market

In its latest monthly report, India's Central Drugs Standard Control Organisation (CDSCO) has found more than 50 drugs to be Not of Standard Quality (NSQ), underlining the massive gap in quality control measures in commonly used medications. These drugs include basic essential drugs like paracetamol, calcium and vitamin D3 tablets, anti-diabetes and anti-hypertension pills.
Eka Care

India Leads the Global Fight Against HIV: A Model of Success

India has recorded a 44% decline in new HIV infections since 2010, which is more than the global average reduction of 39%.
Eka Care
September 26, 2024

‍Second Case of Mpox in Kerala: First in India with More Lethal Clade 1b Strain‍

This marks the first reported instance of this strain in India. The World Health Organization has declared this strain, which had never before been seen in India, a public health emergency last year.
Eka Care
September 25, 2024

India’s First Gastro AI Academy Launched in Mumbai

India's renowned gastroenterologists have established the country's first Gastro AI Academy in Mumbai, in an academic partnership with FUJIFILM India, marking a pioneering initiative in the medical field.
Eka Care
September 25, 2024

Study Finds Microplastics in Brain Tissue

A new study published in JAMA Network Open has revealed the presence of microplastics, defined as particles smaller than 5mm, in vital human organs, including the brain. The pollutants are found in the olfactory bulb of the brain that processes smell, indicating a likely nasal entry point. Microplastics have already been discovered in nearly every organ in the human body.
Eka Care
September 24, 2024

Statin Use Linked to Better Outcomes in Elderly Patients

The study, published in the journal Heart, analyzed data from over 20,000 UK patients aged 70 and older. It found that in addition to reduction of LDL levels, statin use significantly increased quality-adjusted life years (QALYs).
Eka Care
September 21, 2024

India's Healthtech Sector: Poised for a Reboot Amid Funding Challenges

India’s healthtech sector, once expected to hit $21 Bn by 2025, has seen mixed fortunes since the pandemic. Despite a surge in tech adoption across sectors during COVID-19, the healthtech space has struggled to attract consistent investor interest. 

Groundbreaking Brain Implant Restores Independence for ALS Patient

A new brain-computer interface implanted into a blood vessel on the surface of the patient's brain gave him completely hands-free control over smart home devices, streaming television shows, playing music, video calling friends and even online shopping using only his thoughts.
September 20, 2024

Air pollution : A Major Health and Economic Burden in India

India's air pollution problem is causing significant damage to health; increasing incidents of respiratory, cardiovascular, neurological diseases, cancer and even preterm births leading to an economic burden in the form of higher healthcare costs.
September 20, 2024

Second Mpox Case Confirmed in Kerala: UAE Returnee Tests Positive

A 38-year-old man from Malappuram district in Kerala tested positive for Mpox after returning from the UAE, announced Kerala Health Minister Veena George. This marks the second Mpox case in India this year.
Eka Care
September 19, 2024

Union Health Minister JP Nadda Urges Hospitals to Embrace Digital Technology for Patient Data Management

Addressing a virtual event organized by the National Accreditation Board for Hospitals (NABH) on World Patient Safety Day, Union Health Minister JP Nadda emphasized the importance of digitizing healthcare to reduce paperwork, enhance interoperability, and streamline access to patient information across care delivery points, particularly when transferring data from one hospital to another.
Eka Care
September 19, 2024

Millions of Lives at Risk Due to Antimicrobial Resistance: Lancet Study

Deaths in people aged over 70 due to antimicrobial resistance increased by 80% between 1990 and 2021. At the same time, there has been a 50% decrease in deaths of children under five years of age, mainly due to reductions in sepsis and other infections.
Eka Care
September 18, 2024

Apple Watch Receives FDA Clearance for Sleep Apnea Detection

This feature, not intended as a diagnostic tool, will use the watch's built-in accelerometer to track wrist movements during sleep. Users will be alerted after 10 nights of data collection in any 30 day period if they are showing signs of sleep apnea
Eka Care
September 18, 2024

Car Cabin Air Could Pose Cancer, Neurological, and Reproductive Risks: CPCB Study

The CPCB report suggests these chemicals originate from seat foam used to meet outdated fire safety standards.These are associated with a variety of health problems, including cancer, neurotoxic effects and possible reproductive harm.
Eka Care
September 17, 2024

Nipah Virus Claims Another Life in Kerala: Second Death This Year

The health department has traced 151 individuals who came into contact with the victim and are closely monitoring them for symptoms. Five others were symptomatic and awaiting their test results.When
Eka Care
September 17, 2024

Leading Rehabilitation in USA Boosts Patient Outcomes and Revenue with AI-Driven CogPT Platform

Patient satisfaction scores and attendance rates have increased, along with soaring financial returns per visit by 3 to 5 per cent. The platform has been key to streamlining therapist workflows, helping them make better use of their time during sessions and increasing billing efficiency.
Eka Care
September 17, 2024

ICMR to Launch India’s First Evidence-Based Antibiotic Guidelines for Respiratory Infections and Pneumonia

This groundbreaking initiative will answer important clinical questions, including ideal time to initiate, switch or discontinue empirical antibiotic therapy and the choice of antibiotic class. The goal of this program is to enhance antibiotic stewardship and clinical outcomes nationwide.
Dr Arun Kumar

WHO Updates Influenza Care Guidelines, Includes Pandemic Readiness Measures

New guidance pertains to the use of antiviral agents as well as immune modulating steroids, addressing seasonal influenza viruses and a novel type A influenza that has been causing severe illness in infected people
September 16, 2024

WHO prequalifies first mpox vaccine

The MVA-BN vaccine, reviewed by WHO and the EMA regulatory authorities, showed results with an effectiveness rate of 76% after a single dose and 82% when given in two doses, four weeks apart
September 14, 2024

India Expands AB PM-JAY to Cover All Elderly Individuals Aged 70 and Above

The Government of India is set to expand the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) program to cover all senior citizens aged 70 years and above, regardless of their income. This will provide an annual health cover of Rs 5 lakh per family for treatment at secondary and tertiary care hospitals.
September 16, 2024

California’s AI Bill: A new era of AI Safety and Accountability

SB-1047, seen as one of the first major legislative steps aimed at regulating the development of advanced AI systems,has drawn mixed reactions from the tech industry.
Dr Sanjana SN
September 14, 2024

FDA to Probe Possible Heavy Metal Presence in Tampons

The action comes after a recent article that has led to the discovery of lead and other metals in 30 tampons purchased from both online retailers as well as stores located in U.S., U.K., and Greece.
Dr Sanjana SN
September 13, 2024

GST Council: To Review GST On Insurance Premiums & Tax Rate Reduced On Cancer Drugs

The Group of Ministers (GoM) has been set up by the GST Council under Union Finance Minister Nirmala Sitharaman to review the current Goods and Services Tax (GST) on life and health insurance premiums.
Dr Sanjana SN
September 13, 2024

India Launches National Medical Register Portal for Allopathic Doctors

Launched on August 23, 2024, the NMR is proposed to be a National composite listing of all allopathic (MBBS Graduate) Doctors registered and eligible for Medical Practise in India.
Dr Sanjana SN
September 13, 2024

Pandemic Lockdowns Linked to Premature Brain Aging in Teens as per Washington Study

A new study from the University of Washington reveals that COVID-19 pandemic lockdowns may have led to premature aging of teen brains
Dr Sanjana SN
September 11, 2024

India’s First Eye Drop for Presbyopia

India’s first eye drop designed to revolutionize the treatment of presbyopia, a prevalent age-related vision impairment affecting millions of Indians.
Dr Sanjana SN
September 11, 2024

World's First Remote Tele-Endoscopy Conducted by CUHK and ETH Zurich

In a groundbreaking advancement CUHK and ETH Zurich successfully conducted the world’s first in vivo teleoperated magnetic endoscopy using an animal model, over a distance of 9300 km.
Dr Sanjana SN
September 10, 2024

Ministry of Health confirms first case of Mpox Virus in Delhi - Detected virus is not part of the current public health emergency‍

A young male who recently traveled from a country endemic to Mpox has tested positive for the presence of Mpox West African Clade 2.
Dr Sanjana SN

New zoonotic viruses identified in a latest study in China

The study suggests that these animals raised for fur could serve as reservoirs for emerging pathogens possibly sparking a new pandemic
Dr Sanjana SN
September 7, 2024

UNICEF issues emergency tender to procure more vaccines for Mpox

This tender will ensure immediate access to vaccine and scale up production to potentially provide 12 million doses by the end of 2025, by working together with Africa CDC, GAVI and other partners
Dr Sanjana SN
September 7, 2024

Virtual Weight Loss Management Launched by Ochsner

Through digital tools like mobile app, patients can engage with clinicians, health coaches and dieticians for personalised guidance of their weight loss journey.
Dr Sanjana SN
September 7, 2024

Eka.Care Raises $15 Million in Series A Funding

Eka.Care, a leading healthcare startup, has successfully raised $15 million in its Series A funding round led by a prominent venture capital firm. lkajsbdliuablidbalsiubas
Amit Bharti
June 8, 2022

Eka.Care Launches New AI-Based Health Monitoring Feature

Eka.Care has introduced a new AI-based health monitoring feature that aims to provide personalized health insights to users.
September 5, 2024

Eka.Care Partners with Major Hospitals to Expand Services

Eka.Care has partnered with several major hospitals across India to broaden its range of healthcare services and improve accessibility for patients.
June 8, 2022

ADA’s 2025 Diabetes Guidelines: What’s New for Better Patient Outcomes?

The American Diabetes Association (ADA) has unveiled its Standards of Care in Diabetes-2025, a comprehensive guide aimed at improving the diagnosis, management, and outcomes of diabetes care. Grounded in the latest research and clinical trials, these guidelines offer actionable strategies to help healthcare professionals deliver optimal care.
December 11, 2024

Yoga as a Game-Changer in Diabetes Prevention: RSSDI Study Highlights 40% Risk Reduction

A groundbreaking study released by Union Minister Dr. Jitendra Singh has revealed that a daily 40-minute yoga routine, incorporating select asanas and pranayama, can reduce the risk of developing Type-2 diabetes by approximately 40% in prediabetic individuals. The study, titled “Yoga and Prevention of Type 2 Diabetes – The Indian Prevention of Diabetes Study”, was conducted by the Research Society for the Study of Diabetes in India (RSSDI) and published in the esteemed journal Diabetes and Metabolic Syndrome: Clinical Research and Reviews.
December 14, 2024

Mysterious Deaths in J&K’s Rajouri: Viral Infection Suspected, Probe Underway

Health officials in Jammu and Kashmir are investigating a series of mysterious deaths in Badhaal village, Rajouri district, that claimed seven lives, including five from a single family. Initial suspicions of food poisoning have shifted toward a possible viral infection, though conclusive evidence remains pending.
December 18, 2024

Participate in India’s healthcare revolution

Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)

Create ABHA ID

Popular topics

#
funding